Barry S. Ticho
2023
In 2023, Barry S. Ticho earned a total compensation of $1.6M as Chief Medical Officer at Stoke Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $177,934 |
|---|---|
| Option Awards | $474,186 |
| Salary | $494,259 |
| Stock Awards | $489,272 |
| Other | $12,356 |
| Total | $1,648,007 |
Ticho received $494.3K in salary, accounting for 30% of the total pay in 2023.
Ticho also received $177.9K in non-equity incentive plan, $474.2K in option awards, $489.3K in stock awards and $12.4K in other compensation.
Rankings
In 2023, Barry S. Ticho's compensation ranked 700th out of 3,006 executives tracked by ExecPay. In other words, Ticho earned more than 76.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 700 out of 3,006 | 77th |
Division Manufacturing | 397 out of 1,650 | 76th |
Major group Chemicals And Allied Products | 271 out of 918 | 71st |
Industry group Drugs | 265 out of 881 | 70th |
Industry Pharmaceutical Preparations | 171 out of 637 | 73rd |
Source: SEC filing on April 23, 2024.
Ticho's colleagues
We found two more compensation records of executives who worked with Barry S. Ticho at Stoke Therapeutics in 2023.